Triple-negative breast cancer (TNBC), not expressing estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) accounts for 15-20% of all breast cancer cases. Here, ESR1 is linked to triple-negative breast carcinoma.